Hostname: page-component-745bb68f8f-mzp66 Total loading time: 0 Render date: 2025-02-06T09:13:18.238Z Has data issue: false hasContentIssue false

Management of Kikuchi’s disease using glucocorticoid

Published online by Cambridge University Press:  08 March 2006

Yong Ju Jang
Affiliation:
Department of Otolaryngology, Dankook University College of Medicine, Cheonan, Choongnam-Do, Korea.
Keun Hwan Park
Affiliation:
Department of Otolaryngology, Dankook University College of Medicine, Cheonan, Choongnam-Do, Korea.
Hyun Jung Seok
Affiliation:
Department of Otolaryngology, Dankook University College of Medicine, Cheonan, Choongnam-Do, Korea.
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Histiocytic necrotizing lymphadenitis, or Kikuchi’s disease, is a self-limiting cervical lymphadenitis of unknown origin. Since no specific treatment has been reported for Kikuchi’s disease to date, once a diagnosis of Kikuchi’s disease has been established, the role of the physician has been limited only to treating the symptoms. Sometimes, however, the clinical manifestations of the disease can be very distressing for the patients. Thus, a more aggressive form of treatment may be required for the patients who suffer from severe and persisting symptoms and recurrence. We present three cases of Kikuchi’s disease that benefited significantly from systemic administration of prednisone.

Type
Brief Report
Copyright
Royal Society of Medicine Press Limited 2000